Page 1

Lantheus FIND FIGHT > FOLLOW ™ Lantheus Holdings , Inc. Reports First Quarter 2021 Financial Results May 4 , 2021 • Worldwide revenue of $ 92.5 million for the first quarter 2021 , representing an increase of 2.0 % from the prior year period • Net income of $ 9.0 million for the first quarter 2021 , compared to net income of $ 3.3 million in the prior year period • GAAP fully diluted EPS of $ 0.13 for the first quarter 2021 , compared to GAAP fully diluted EPS of $ 0.08 in the prior year period ; adjusted fully diluted EPS of $ 0.05 for the first quarter 2021 , compared to adjusted fully diluted EPS of $ 0.36 in the prior year period • Net cash provided by operating activities was $ 9.8 million for the first quarter 2021. Free cash flow was $ 7.3 million in the first quarter 2021 • The Company provides second quarter 2021 revenue and adjusted diluted earnings per share guidance ; updates full year guidance NORTH BILLERICA , Mass .-- ( BUSINESS WIRE ) -- May 4 , 2021-- Lantheus Holdings , Inc. ( NASDAQ : LNTH ) ( Lantheus ) , an established leader and fully integrated provider of innovative imaging diagnostics , targeted therapeutics and artificial intelligence solutions to find , fight and follow serious medical conditions , today reported financial results for its first quarter ended March 31 , 2021 . The Company's worldwide revenue for the first quarter of 2021 totaled $ 92.5 million , compared with $ 90.7 million for the first quarter of 2020 , representing an increase of 2.0 % from the prior year period . The Company's first quarter 2021 net income was $ 9.0 million , or $ 0.13 per fully diluted share , as compared to net income of $ 3.3 million , or $ 0.08 per fully diluted share for the first quarter of 2020 . The Company's first quarter 2021 adjusted fully diluted earnings per share were $ 0.05 , as compared to $ 0.36 for the first quarter of 2020 , representing a decrease of 86.3 % from the prior year period . Lastly , net cash provided by operating activities was $ 9.8 million for the first quarter 2021. Free Cash Flow was $ 7.3 million in the first quarter of 2021 , representing an increase of approximately $ 0.6 million from the prior year period . " We had a strong start to 2021 with solid first quarter revenue and earnings overperformance driven mainly by DEFINITY volume . While COVID - 19 did impact the early part of the quarter , we are encouraged by the continued trend toward in - person delivery of healthcare , " said Mary Anne Heino , President and CEO . " Currently , we are focused on preparation for the potential FDA approval and commercial launch of PyL , a best - in - class PSMA prostate cancer imaging agent , to help drive long - term value for patients , healthcare professionals , and shareholders . " Outlook The Company updates its guidance for full year 2021 and offers the following guidance for the second quarter . Q2 FY 2021 Revenue Q2 FY 2021 Adjusted Diluted EPS FY 2021 Revenue FY 2021 Adjusted Diluted EPS Q2 Guidance Issued May 4 , 2021 Previous Guidance Issued February 25 , 2021 $ 93 million $ 97 million $ 0.03 - $ 0.06 FY Guidance Updated May 4 , 2021 $ 390 million - $ 400 million $ 0.36 - $ 0.41 N / A N / A FY Guidance Issued February 25 , 2021 $ 385 million - $ 400 million $ 0.34 $ 0.39 On a forward - looking basis , the Company does not provide GAAP income per common share guidance or a reconciliation of adjusted fully diluted EPS to GAAP income per common share because the Company is unable to predict with reasonable certainty business development and acquisition related expenses , purchase accounting fair value adjustments , and any one - time , non - recurring charges . These items are uncertain , depend on various factors , and could be material to results computed in accordance with GAAP . As a result , it is the Company's view that a quantitative reconciliation of adjusted fully diluted EPS on a forward - looking basis is not available without unreasonable effort . Internet Posting of Information The Company routinely posts information that may be important to investors in the " Investors " section of its website at www.lantheus.com . The Company encourages investors and potential investors to consult its website regularly for important information about the Company . Conference Call and Webcast As previously announced , the Company will host a conference call and webcast on Tuesday , May 4 , 2021 at 8:00 a.m. ET . To access the live conference call via telephone , please dial 1-866-498-8390 ( U.S. callers ) or 1-678-509-7599 ( international callers ) and provide passcode 9275247. A live webcast will be available in the Investors section of the Company's website at www.lantheus.com .